Comparison of Nebulized Long-Acting Muscarinic Antagonist Revefenacin to Ipratropium in COPD Patients With Acute Respiratory Failure Requiring Mechanical Ventilation: Results of the RARICO Study.
Background Revefenacin is a nebulized long-acting muscarinic antagonist approved for maintenance therapy in stable chronic obstructive pulmonary disease (COPD). We conducted a pilot study to evaluate the feasibility and safety of revefenacin in mechanically ventilated COPD patients with acute respiratory failure (ARF),...